Adlai Nortye Ltd American Depositary Shares (ANL)

$1.50 +0.03 (2.04%)
Market Cap 57.20M
Revenue (ttm) 0.00
Net Income (ttm) -51.87M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 1.03
Volume 846
Avg Vol 19,594
Day's Range N/A - N/A
Shares Out 36.90M
Stochastic %K 21%
Beta -0.83
Analysts Hold
Price Target $9.00

Company Profile

Adlai Nortye Ltd., a clinical-stage biotechnology company, engages in the research and development of pharmaceutical products. Its lead product is AN2025, a pan-phosphoinositide 3-kinase inhibitor, which is in Phase III clinical trials for the treatment of recurrent or metastatic head and neck squamous cell carcinomas. The company is also developing AN0025, a small molecule prostaglandin E receptor 4 antagonist to modulate the tumor microenvironment that is in a Phase Ib clinical trial for the t...

Industry: Biotechnology
Sector: Healthcare
Phone: 848 230 7430
Address:
Ugland House, PO Box 309, Grand Cayman, Cayman Islands
BillionerOfKing
BillionerOfKing Feb. 20 at 2:48 AM
$ANL Current Stock Price: $9.86
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 18 at 10:06 PM
$ANL RSI: 78.15, MACD: 1.9246 Vol: 3.30, MA20: 7.53, MA50: 3.90 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
topstockalerts
topstockalerts Feb. 18 at 7:50 PM
$ANL Interesting spot for a momentum swing 💡. Price is holding strength. Buyers are clearly engaged.
0 · Reply
johnjaha
johnjaha Feb. 18 at 7:44 PM
$ANL $LNKS $SGN Blocked for Spamming tickers. Only one ticker. SGN.
0 · Reply
RubenWashinton240
RubenWashinton240 Feb. 18 at 12:46 PM
$ANL Energy infrastructure exposure tied to LNG demand cycles.
0 · Reply
Godwins26
Godwins26 Feb. 17 at 1:32 AM
We are open!!! 😊 $RIME $TCGL $ANL
2 · Reply
Gtrading1234
Gtrading1234 Feb. 15 at 5:47 AM
$ANL
0 · Reply
Godwins26
Godwins26 Feb. 14 at 12:22 AM
Lottery 🎰 Watchlist 🤑 $RIME $ANL $TCGL
0 · Reply
Paraboljoker
Paraboljoker Feb. 13 at 9:43 PM
$JDZG Usually when i have a ticker on my radar it’s a leading indicator to go parabolic sooner than way later👀 make sure to follow @Paraboljoker for more 200% Wins/explosive upcoming swingplays like $JDZG 🔥🃏 + see my bio 🔗 Nanocaps n pennies going to dollarz these days🤙🏻 💸 ! $GITS $BNAI $LNKS $ANL
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 12 at 3:35 PM
$ANL Current Stock Price: $9.78
0 · Reply
Latest News on ANL
Adlai Nortye Announces First Patient Enrolled in Global Phase 1 Trial of Pan-RAS (ON) Inhibitor AN9025 for Solid Tumors Harboring RAS Mutations

Feb 12, 2026, 4:00 AM EST - 11 days ago

Adlai Nortye Announces First Patient Enrolled in Global Phase 1 Trial of Pan-RAS (ON) Inhibitor AN9025 for Solid Tumors Harboring RAS Mutations

Adlai Nortye Announces $140.0 Million Private Placement Equity Financing

Feb 3, 2026, 7:00 AM EST - 20 days ago

Adlai Nortye Announces $140.0 Million Private Placement Equity Financing

Adlai Nortye Enters Exclusive License Agreement with ASK Pharm for Pan-RAS (ON) Inhibitor AN9025 in Greater China

Dec 29, 2025, 6:00 AM EST - 2 months ago

Adlai Nortye Enters Exclusive License Agreement with ASK Pharm for Pan-RAS (ON) Inhibitor AN9025 in Greater China

Adlai Nortye to Present Short Talk at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Oct 13, 2025, 11:07 PM EDT - 4 months ago

Adlai Nortye to Present Short Talk at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Adlai Nortye Ltd. to Present Encouraging Data of the Combination of AN0025 and Definitive Chemoradiotherapy (dCRT) at ASCO 2024

May 23, 2024, 9:03 PM EDT - 1 year ago

Adlai Nortye Ltd. to Present Encouraging Data of the Combination of AN0025 and Definitive Chemoradiotherapy (dCRT) at ASCO 2024

Adlai Nortye Announces First Patient Dosed in Randomized Phase II Clinical Trial of Palupiprant (AN0025) for the Treatment of Locally Advanced Rectal Cancer with Radiation Therapy

May 22, 2024, 8:00 AM EDT - 1 year ago

Adlai Nortye Announces First Patient Dosed in Randomized Phase II Clinical Trial of Palupiprant (AN0025) for the Treatment of Locally Advanced Rectal Cancer with Radiation Therapy

Adlai Nortye Announces Appointment of Dr. Archie Tse as the Head of Research & Development

Mar 29, 2024, 6:00 AM EDT - 2 years ago

Adlai Nortye Announces Appointment of Dr. Archie Tse as the Head of Research & Development

Adlai Nortye Announces Completion of Patient Enrollment in Global Phase III Clinical Trial of Buparlisib (AN2025) in Combination with Paclitaxel for the Treatment of Recurrent or Metastatic HNSCC

Nov 17, 2023, 7:30 AM EST - 2 years ago

Adlai Nortye Announces Completion of Patient Enrollment in Global Phase III Clinical Trial of Buparlisib (AN2025) in Combination with Paclitaxel for the Treatment of Recurrent or Metastatic HNSCC

Adlai Nortye Ltd. & Nucleai awarded ESMO 2023 BEST Poster Award

Oct 23, 2023, 8:12 AM EDT - 2 years ago

Adlai Nortye Ltd. & Nucleai awarded ESMO 2023 BEST Poster Award

Adlai Nortye Dives In Nasdaq Debut, As Key Product Faces Hurdles

Oct 13, 2023, 8:00 AM EDT - 2 years ago

Adlai Nortye Dives In Nasdaq Debut, As Key Product Faces Hurdles

Adlai Nortye Ltd. Announces Closing of Initial Public Offering

Oct 3, 2023, 12:05 PM EDT - 2 years ago

Adlai Nortye Ltd. Announces Closing of Initial Public Offering

U.S. IPO Weekly Recap: Holdover Adlai Nortye Leads 4 IPO Week As More Small Deals Enter The Pipeline

Sep 30, 2023, 3:30 AM EDT - 2 years ago

U.S. IPO Weekly Recap: Holdover Adlai Nortye Leads 4 IPO Week As More Small Deals Enter The Pipeline

BIRK KHIW LRE VSME

Adlai Nortye Ltd. Announces Pricing of Initial Public Offering

Sep 29, 2023, 2:46 AM EDT - 2 years ago

Adlai Nortye Ltd. Announces Pricing of Initial Public Offering

U.S. IPO Weekly Recap: August Wraps Up With 1 Nano-Cap

Sep 3, 2023, 10:45 AM EDT - 2 years ago

U.S. IPO Weekly Recap: August Wraps Up With 1 Nano-Cap

ABNB ARM CART IPO IPOS SNOW

U.S. IPO Weekly Recap: IPO Market Sees Fitness, Liquor Marketing, And Medical Devices

Aug 12, 2023, 6:00 AM EDT - 2 years ago

U.S. IPO Weekly Recap: IPO Market Sees Fitness, Liquor Marketing, And Medical Devices

FTEL NRXS NWGL VFS

IPO Update: Adlai Nortye Readies $72 Million U.S. IPO

Aug 11, 2023, 2:16 PM EDT - 2 years ago

IPO Update: Adlai Nortye Readies $72 Million U.S. IPO

Cancer treatment company Adlai Nortye sets terms in IPO

Aug 11, 2023, 7:05 AM EDT - 2 years ago

Cancer treatment company Adlai Nortye sets terms in IPO

Adlai Nortye Ltd. Begins U.S. IPO Rollout

Jul 31, 2023, 6:17 PM EDT - 2 years ago

Adlai Nortye Ltd. Begins U.S. IPO Rollout

BillionerOfKing
BillionerOfKing Feb. 20 at 2:48 AM
$ANL Current Stock Price: $9.86
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 18 at 10:06 PM
$ANL RSI: 78.15, MACD: 1.9246 Vol: 3.30, MA20: 7.53, MA50: 3.90 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
topstockalerts
topstockalerts Feb. 18 at 7:50 PM
$ANL Interesting spot for a momentum swing 💡. Price is holding strength. Buyers are clearly engaged.
0 · Reply
johnjaha
johnjaha Feb. 18 at 7:44 PM
$ANL $LNKS $SGN Blocked for Spamming tickers. Only one ticker. SGN.
0 · Reply
RubenWashinton240
RubenWashinton240 Feb. 18 at 12:46 PM
$ANL Energy infrastructure exposure tied to LNG demand cycles.
0 · Reply
Godwins26
Godwins26 Feb. 17 at 1:32 AM
We are open!!! 😊 $RIME $TCGL $ANL
2 · Reply
Gtrading1234
Gtrading1234 Feb. 15 at 5:47 AM
$ANL
0 · Reply
Godwins26
Godwins26 Feb. 14 at 12:22 AM
Lottery 🎰 Watchlist 🤑 $RIME $ANL $TCGL
0 · Reply
Paraboljoker
Paraboljoker Feb. 13 at 9:43 PM
$JDZG Usually when i have a ticker on my radar it’s a leading indicator to go parabolic sooner than way later👀 make sure to follow @Paraboljoker for more 200% Wins/explosive upcoming swingplays like $JDZG 🔥🃏 + see my bio 🔗 Nanocaps n pennies going to dollarz these days🤙🏻 💸 ! $GITS $BNAI $LNKS $ANL
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 12 at 3:35 PM
$ANL Current Stock Price: $9.78
0 · Reply
RicardoCastro251
RicardoCastro251 Feb. 11 at 5:23 PM
$ANL Anl or unknown; not a standard ticker; speculative.
0 · Reply
Godwins26
Godwins26 Feb. 11 at 6:29 AM
$QNCX $TCGL $ROIV $ANL $BNAI
0 · Reply
Godwins26
Godwins26 Feb. 11 at 6:28 AM
Lottery 🎰 Watchlist $QNCX is this the next lottery play and will you be rich 🤑 $TCGL $ROIV $ANL $BNAI
1 · Reply
Godwins26
Godwins26 Feb. 11 at 4:59 AM
Lottery 🎰 Watchlist 🚀 $QNCX can we see $430? 🤔 $TCGL $ANL
2 · Reply
Godwins26
Godwins26 Feb. 10 at 11:46 PM
Watchlist 🚀 $QNCX can it hit $430 $TCGL $BNAI $ANL
1 · Reply
Godwins26
Godwins26 Feb. 10 at 7:49 PM
Watchlist 😊 $QNCX we doing a 500% $TCGL $ANL $SMX
0 · Reply
Marcelline
Marcelline Feb. 9 at 1:13 PM
$ANL $CETX $MIGI $OPGN $TGL
0 · Reply
Stock_Catcher
Stock_Catcher Feb. 9 at 12:27 AM
Money Monday Watchlist Pt.8 $OPGN $ANL $TGL $CETX $MIGI Looking for a 1000% Runner
0 · Reply
Tradebub
Tradebub Feb. 6 at 3:54 PM
$ANL headquartered in Hangzhou, China
0 · Reply
Tradebub
Tradebub Feb. 6 at 3:48 PM
$ANL Crash is coming. Look out below...
0 · Reply
bugjun3
bugjun3 Feb. 6 at 4:08 AM
$ANL This one looks bullish?
0 · Reply
ZachKing
ZachKing Feb. 5 at 1:24 PM
$ANL
0 · Reply